Clinical Trial Update: Human African Trypanosomiasis: First in Man Clinical Trial of a New Medicinal Product, the SCYX-7158 [Phase 1]

View source ↗

Summary

A first-in-man, Phase 1 trial of SCYX-7158 for Human African Trypanosomiasis has completed, with DNDi listed as sponsor.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Human African Trypanosomiasis

Drugs mentioned

• SCYX-7158

Snippet

Sponsor: Drugs for Neglected Diseases | Conditions: Trypanosomiasis, Trypanosomiasis, African | Phase 1 | Status: COMPLETED